Meeder Asset Management Inc Omeros Corp Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$12.21 - $16.99 $8,058 - $11,213	-660 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $4,108 - $8,972	455 Added 221.95%	660 $9,000
Q4 2019 Feb 13, 2020	BUY	$13.01 - $17.15 $2,667 - $3,515	205 New	205 $3,000
Q1 2019 Apr 16, 2019	SELL	$11.65 - $17.72 $4,694 - $7,141	-403 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$10.72 - $16.73 $1,661 - $2,593	155 Added 62.5%	403 $4,000
Q3 2018 Nov 02, 2018	BUY	$17.73 - $26.69 $2,960 - $4,457	167 Added 206.17%	248 $0
Q2 2018 Jul 24, 2018	BUY	$10.79 - $24.44 $873 - $1,979	81 New	81 $0
Q1 2018 May 03, 2018	SELL	$9.0 - $20.16 $306 - $685	-34 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$13.26 - $22.86 $450 - $777	34	34 $1,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.